Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Dr Philippa Gardner

Dr Philippa Gardner
Healthcare Analyst

Lala Gregorek

Lala Gregorek
Director of Healthcare Research and Strategy

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Nuevolution Xbrane
LifeWatch Acarix
Biondvax Pharmaceuticals Quantum Genomics

Recent QuickViews

Smith & Nephew

All parts now in place to move forward

Pharmaceutical & healthcare | published 14/02/2017
Nuevolution

Delivering on promises

Pharmaceutical & healthcare | published 04/01/2017
Nuevolution

Amgen deal: A significant step forward

Pharmaceutical & healthcare | published 23/11/2016
aap Implantate

Progression of LOQTEQ portfolio

Pharmaceutical & healthcare | published 21/11/2016

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

SymBio Pharmaceuticals

Moving ahead on all fronts

ADR Outlook | Pharmaceutical & healthcare | 27/02/2017

During 2017 we expect updates on all three of SymBio’s main assets. We expect Treakisym sales growth via partner Eisai following approvals during…

Hutchison China MediTech

POC positive - so far so good for savolitinib in PRCC

Update | Pharmaceutical & healthcare | 27/02/2017

Hutchison (HCM) and partner AstraZeneca presented positive preliminary data from the ongoing phase II proof-of-concept trial evaluating savolitinib (c-Met…

Photocure

A year of solid growth

Update | Pharmaceutical & healthcare | 27/02/2017

Photocure announced results for 2016 showing strong growth for the Hexvix/Cysview franchise. Total sales for the product were up 13% to NOK131m, driven…

SymBio Pharmaceuticals

Moving ahead on all fronts

Outlook | Pharmaceutical & healthcare | 27/02/2017

During 2017 we expect updates on all three of SymBio’s main assets. We expect Treakisym sales growth via partner Eisai following approvals during…

Abzena

Solid trading update despite increased costs

Update | Pharmaceutical & healthcare | 23/02/2017

Abzena announced a solid business update including a 12th Abzena inside product entering the clinic. FY17 revenue is in line with expectations; however,…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies